Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma

Recurrence of disease due to chemotherapy drug resistance remains a major obstacle to a more successful survival outcome of multiple myeloma (MM). Overcoming drug resistance and salvaging patients with relapsed and/or refractory (R/R) MM is an urgent and unmet medical need. Several new personalized...

Descripción completa

Detalles Bibliográficos
Autores principales: Uckun, Fatih M., Qazi, Sanjive, Demirer, Taner, Champlin, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354702/
https://www.ncbi.nlm.nih.gov/pubmed/30545798
http://dx.doi.org/10.1016/j.ebiom.2018.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354702/
https://www.ncbi.nlm.nih.gov/pubmed/30545798
http://dx.doi.org/10.1016/j.ebiom.2018.12.004

Ejemplares similares